Rituximab may be a safe and effective option for frequently relapsing or steroid-dependent adult-onset nephrotic syndrome, ...

I am currently caring for a 74-year-old man with a 2-month history of progressive nephrotic syndrome and cholestatic jaundice. What are the most likely diagnoses to consider? This is a challenging ...

Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

With funding from charity Kidney Research UK, Dr Carl May from Bristol Medical School and his team have identified a new treatment pathway for patients with non-genetic (idiopathic) nephrotic syndrome ...

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated activity of cdc42 is a critical initiation event leading to proteinuria, and ...

Researchers sought to better understand the distinct immunological pathways in AAV and nephrotic syndrome, which could lead to better diagnosis. A better understanding of the distinct immunological ...

Children with frequently relapsing or steroid-dependent nephrotic syndrome had a significantly longer relapse-free survival period with tacrolimus than with mycophenolate mofetil. Relapse-free ...

Please provide your email address to receive an email when new articles are posted on . The tacrolimus group had a 1.86-fold higher rate of relapse-free survival vs. those assigned mycophenolate ...

For children with nephrotic syndrome, there was no difference in time to relapse between two commonly used non-steroid immunosuppressive medications, according to an observational study that emulated ...